Monkeypox future or investigational therapies

Revision as of 11:08, 16 June 2022 by Bassel.almarie (talk | contribs) (Created page with "__NOTOC__ {{Monkeypox}} {{CMG}}; {{AE}} Bassel Almarie, MD ==Overview== Countries are developing policies to define high risk groups to receive vaccines. Clinical investigations will be running to evaluate the appropriateness of vaccination to contain the outbreak<ref name="urlMonkeypox">{{cite web |url=https://www.who.int/news-room/fact-sheets/detail/monkeypox |title=Monkeypox |format= |work= |accessdate=2022-06-16}}</ref>. ==Future or investigational therapies== Co...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Monkeypox Microchapters

Home

Patient Info

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Monkeypox

Differentiating Monkeypox from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Monkeypox future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Monkeypox future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Monkeypox future or investigational therapies

CDC on Monkeypox future or investigational therapies

Monkeypox future or investigational therapies in the news

Blogs on Monkeypox future or investigational therapies

Directions to Hospitals Treating Monkeypox

Risk calculators and risk factors for Monkeypox future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Bassel Almarie, MD

Overview

Countries are developing policies to define high risk groups to receive vaccines. Clinical investigations will be running to evaluate the appropriateness of vaccination to contain the outbreak[1].

Future or investigational therapies

Countries are developing policies to define high risk groups to receive vaccines. Clinical investigations will be running to evaluate the appropriateness of vaccination to contain the outbreak[1].

References

  1. 1.0 1.1 "Monkeypox". Retrieved 2022-06-16.